Skip to content 
A major drug safety alert has been issued after health authorities confirmed that hundreds of thousands of bottles of a commonly prescribed blood pressure medication were recalled due to concerns about a possible cancer-causing impurity.
The recall has raised concerns among patients who rely on daily medication to manage high blood pressure — one of the most common chronic health conditions worldwide.
Here’s what you need to know in simple terms.
💊 What Happened?
According to health regulators, more than 580,000 to nearly 600,000 bottles of a blood pressure medicine called prazosin hydrochloride were voluntarily recalled by the manufacturer.
The affected medication was found to potentially contain nitrosamine impurities, a type of chemical that can form during drug manufacturing or storage. These substances are known to be potentially carcinogenic (cancer-causing) when exposure is long-term or at high levels.
⚠️ Why Is This Dangerous?
Nitrosamines are not new in pharmaceutical safety alerts. They have previously been detected in several medications globally.
Health experts explain:
- Small exposure is generally not immediately harmful
- Long-term high exposure may increase cancer risk
- The risk depends on dosage and duration
Because of this, regulators classify this type of recall as a “Class II risk”, meaning:
👉 The product may cause temporary or reversible health effects
👉 Serious harm is considered unlikely but not impossible
🏭 Which Drug Is Affected?
The recall involves prazosin hydrochloride, a medication commonly used to:
- Treat high blood pressure (hypertension)
- Sometimes help with PTSD-related nightmares and sleep issues
It is widely prescribed and considered an important medication for many patients managing cardiovascular health.
🧪 What Exactly Was Found?
Testing revealed the presence of a specific impurity linked to nitrosamines — chemicals that can sometimes form during pharmaceutical production.
These impurities can appear when:
- Manufacturing processes change
- Raw materials react under certain conditions
- Storage conditions are not optimal
Experts say this issue has been seen before in other blood pressure drugs, leading to global recalls in recent years.